Veterans’ treatment discontinuation differs by type of antipsychotic

veterans treatment discontinuation differs by type of antipsychotic

Sumary of Veterans’ treatment discontinuation differs by type of antipsychotic:

  • July 20, 2021 2 min read Source/Disclosures Disclosures: Weiser reports receiving advisory board, speaker’s and/or consultant fees from and owning stock in Acadia, Dexcel, Janssen, Lundbeck, Minerva, Pfizer, Roche and Teva.
  • Please see the study for all other authors’ relevant financial disclosures.
  • Veterans treated with clozapine, two of the long-acting injectable second-generation antipsychotics and antipsychotic polypharmacy maintained the same antipsychotic therapy for a longer duration vs.
  • Weiser and colleagues speculated about the reason that those who received antipsychotic polypharmacy experienced longer episodes of continuous therapy and lower rates of treatment discontinuation but not of psychiatric hospitalization compared with those who received oral olanzapine.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.